Add BrightSurf on Google Email

Vanderbilt University Medical Center


Vanderbilt researchers identify potential antibody treatment for H7 avian flu

Vanderbilt researchers have identified a new antibody treatment for H7 avian flu with remarkable neutralizing potency, potentially offering short-term protection to people exposed or infected by the virus. The antibodies were isolated from human monoclonal antibodies generated in response to an experimental bird flu vaccine.

SourceVanderbilt University Medical Center·JournalJournal of Clinical Investigation·DateMar 9, 2016

Vanderbilt study finds erectile dysfunction drug may benefit patients at risk for diabetes

A Vanderbilt study found that sildenafil improves insulin sensitivity in people at risk for diabetes, potentially reducing the risk of developing type 2 diabetes. The researchers discovered that sildenafil inhibits an enzyme called phosphodiesterase 5, resulting in relaxation of smooth muscle and increased blood flow.

SourceVanderbilt University Medical Center·JournalThe Journal of Clinical Endocrinology & Metabolism·DateNov 18, 2015